Literature DB >> 5570460

Regulation of hepatic cholesterol biosynthesis by clofibrate administration.

L W White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5570460

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  12 in total

1.  Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.

Authors:  H A Newman; W P Heilman; D T Witiak
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

2.  Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis.

Authors:  S Parthasarathy; D Kritchevsky; W J Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.

Authors:  K Kutz; A Schulte; C Just; H Lindstaedt; B Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

4.  Bezafibrate fails to directly modulate HMG-CoA reductase or LDL catabolism in human mononuclear cells.

Authors:  E F Stange; M Frühholz; M Osenbrügge; F Reimann; H Ditschuneit
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Studies on the mechanism of action of halofenate.

Authors:  L R Mandel
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

6.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

7.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

8.  Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae.

Authors:  M D Greenspan; J I Germershausen
Journal:  J Bacteriol       Date:  1973-02       Impact factor: 3.490

9.  Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.

Authors:  B M Wolfe; J P Kane; R J Havel; H P Brewster
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.

Authors:  M O'Brien; S T Patel; A Mukhopadhyay; H A Newman; D R Feller; S S Kokrady; D T Witiak; R R Lanese; J C Rice
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.